谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: an Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.

Remy Nicolle,Jean-Baptiste Bachet,Alexandre Harle,Juan Iovanna,Pascal Hammel,Vinciane Rebours,Anthony Turpin,Meher Ben Abdelghani,Alice Wei,Emmanuel Mitry,Anthony Lopez,James Biagi,Eric Francois,Pascal Artru,Aurelien Lambert,Daniel J. Renouf,Laure Monard,Marjorie Mauduit,Nelson Dusetti,Thierry Conroy,Jerome Cros

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览27
暂无评分
关键词
Gemcitabine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要